Resources

Health and Family Welfare Ministry’s notification on ‘hydroxychloroquine’

File photo of Nivaquine, tablets containing chloroquine, a commonly used malaria drug that has shown signs of effectiveness against coronavirus.

File photo of Nivaquine, tablets containing chloroquine, a commonly used malaria drug that has shown signs of effectiveness against coronavirus.   | Photo Credit: AFP

Hydroxychloroquine is now a schedule H1 drug, and can be sold on prescription only.

According to a gazette notification issued by the Union Health Ministry, the sale of the drug from now on should be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945. Here is the official notification:

 

Health and Family Welfare Ministry’s notification on ‘hydroxychloroquine’

A letter from the Editor


Dear reader,

We have been keeping you up-to-date with information on the developments in India and the world that have a bearing on our health and wellbeing, our lives and livelihoods, during these difficult times. To enable wide dissemination of news that is in public interest, we have increased the number of articles that can be read free, and extended free trial periods. However, we have a request for those who can afford to subscribe: please do. As we fight disinformation and misinformation, and keep apace with the happenings, we need to commit greater resources to news gathering operations. We promise to deliver quality journalism that stays away from vested interest and political propaganda.

Support Quality Journalism
Recommended for you
This article is closed for comments.
Please Email the Editor

Printable version | Jun 6, 2020 10:38:50 PM | https://www.thehindu.com/news/resources/health-and-family-welfare-ministrys-notification-on-hydroxychloroquine/article31190771.ece

Next Story